Aminosalicylate
Assets acting on this target.
- Class
- Aminosalicylate
- Notes
- openFDA EPC fill 2026-08-24 (exact-name label match: Sulfasalazine); source: https://api.fda.gov/drug/label.json?search=openfda.generic_name%3A%22Sulfasalazine%22+openfda.brand_name%3A%22Sulfasalazine%22&limit=12
By indication
Aminosalicylate drugs compared
9 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| balsalazide disodium (Colazal)Colazal | Bausch Health | small molecule | Approved | Approved in Ulcerative Colitis |
| mesalamine (Apriso)Apriso | Bausch Health | small molecule | Approved | Approved in Ulcerative Colitis |
| Mesalamine (Canasa)Canasa | AbbVie | small molecule | Approved | Approved in Ulcerative Colitis |
| Mesalamine (Lialda)Lialda | Cosmo N.V., Takeda Pharmaceutical Company | small molecule | Approved | Approved in Ulcerative Colitis |
| Mesalamine (Pentasa)Pentasa | Ferring Pharmaceuticals, Takeda Pharmaceutical Company | small molecule | Approved | Approved in Ulcerative Colitis |
| mesalamine (Rowasa)Rowasa | Viatris | small molecule | Approved | Approved in Ulcerative Colitis |
| olsalazine (Dipentum)Dipentum | Viatris | small molecule | Approved | Approved in Ulcerative Colitis |
| Sulfasalazine | Pfizer | small molecule | Approved | Approved in Rheumatoid Arthritis; Approved in Ulcerative Colitis |
| mesalamine (Asacol HD)Asacol HD | AbbVie | small molecule | US approval withdrawn | US approval withdrawn in Ulcerative Colitis |